Lexicon Pharmaceuticals Explodes Higher -- Here's What's Fueling the Surge
Lexicon inks a major collaborative deal and reports a narrow than expected quarterly loss. All in a day's work for a daily top-performer.
Is It Game Over for MannKind Corporation?
Sanofi reports another bad quarter of Afrezza sales, and big changes on the horizon.